Skip to main content
Top
Published in: BMC Infectious Diseases 1/2016

Open Access 01-12-2016 | Research article

Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period

Authors: Petra J. Woestenberg, Jeroen H. T. Tjhie, Hester E. de Melker, Fiona R. M. van der Klis, Jan E. A. M van Bergen, Marianne A. B. van der Sande, Birgit H. B. van Benthem

Published in: BMC Infectious Diseases | Issue 1/2016

Login to get access

Abstract

Background

Genital herpes results in considerable morbidity, including risk of neonatal herpes, and is increasingly being caused by Herpes Simplex Virus (HSV) type 1. Possibly children are less often HSV-1 infected, leaving them susceptible until sexual debut. We assessed changes in the Dutch HSV-1 and HSV-2 seroprevalence over time and determinants associated with HSV seropositivity.

Methods

We used data from two population-based seroepidemiological studies conducted in 1995–6 and 2006–7 with a similar study design. Serum samples of 6 months to 44-year-old participants were tested for type-specific HSV antibodies using HerpesSelect® with a cut-off level of >1.10 for seropositivity. Age and sex-specific HSV-1 and HSV-2 seroprevalence was weighted for the Dutch population. Logistic regression was performed to investigate determinants associated with HSV seropositivity.

Results

Overall, weighted HSV-1 seroprevalence was significantly lower in 2006–7 [42.7 % 95 % confidence interval (CI) 39.9-45.4] than in 1995–6 (47.7 % 95 % CI 44.8-50.7), especially among 10- to 14-year-olds. Overall, weighted HSV-2 seroprevalence remained stable: 6.8 % in 1995–6 and 6.0 % in 2006–7. Adults who ever had sexual intercourse were more often seropositive for HSV-1 [adjusted Odds Ratio (aOR) 1.69 95 % CI 1.33-2.16] and HSV-2 (aOR 2.35 95 % CI 1.23-4.52). Age at sexual debut was the only sexual risk determinant associated with HSV-1 seropositivity.

Conclusions

Because of the lower HSV-1 seroprevalence in 2006–7 compared to 1995–6, more adults are susceptible to genital HSV-1, including women of reproductive age. Given the higher risk of neonatal herpes when HSV is acquired during pregnancy, prevention and control measures during pregnancy also targeting HSV-1, are important.
Appendix
Available only for authorised users
Literature
1.
go back to reference Corey L, Wald A. Genital herpes. In: Holmes KK, Sparling PJ, Stamm WE, Piot P, Wasserheit JN, Corey L, Cohen MS, Watts DH, editors. Sexually transmitted diseases. 4th ed. New York: McGraw-Hill; 2008. p. 399–437. Corey L, Wald A. Genital herpes. In: Holmes KK, Sparling PJ, Stamm WE, Piot P, Wasserheit JN, Corey L, Cohen MS, Watts DH, editors. Sexually transmitted diseases. 4th ed. New York: McGraw-Hill; 2008. p. 399–437.
2.
go back to reference Looker KJ, Magaret AS, May MT, Turner KM, Vickerman P, Gottlieb SL, Newman LM. Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS One. 2015;10(10):e0140765.CrossRefPubMedPubMedCentral Looker KJ, Magaret AS, May MT, Turner KM, Vickerman P, Gottlieb SL, Newman LM. Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS One. 2015;10(10):e0140765.CrossRefPubMedPubMedCentral
3.
go back to reference Hemelaar SJ, Poeran J, Steegers EA, van der Meijden WI. Neonatal herpes infections in The Netherlands in the period 2006–2011. J Matern Fetal Neonatal Med. 2015;28(8):905–9.CrossRefPubMed Hemelaar SJ, Poeran J, Steegers EA, van der Meijden WI. Neonatal herpes infections in The Netherlands in the period 2006–2011. J Matern Fetal Neonatal Med. 2015;28(8):905–9.CrossRefPubMed
4.
go back to reference Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. Aids. 2006;20(1):73–83.CrossRefPubMed Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. Aids. 2006;20(1):73–83.CrossRefPubMed
5.
go back to reference Corey L, Wald A, Celum CL, Quinn TC. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr. 2004;35(5):435–45.CrossRefPubMed Corey L, Wald A, Celum CL, Quinn TC. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr. 2004;35(5):435–45.CrossRefPubMed
6.
go back to reference Scoular A, Norrie J, Gillespie G, Mir N, Carman WF. Longitudinal study of genital infection by herpes simplex virus type 1 in Western Scotland over 15 years. BMJ. 2002;324(7350):1366–7.CrossRefPubMedPubMedCentral Scoular A, Norrie J, Gillespie G, Mir N, Carman WF. Longitudinal study of genital infection by herpes simplex virus type 1 in Western Scotland over 15 years. BMJ. 2002;324(7350):1366–7.CrossRefPubMedPubMedCentral
7.
go back to reference Roberts CM, Pfister JR, Spear SJ. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sexually transmitted diseases. 2003;30(10):797–800.CrossRefPubMed Roberts CM, Pfister JR, Spear SJ. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sexually transmitted diseases. 2003;30(10):797–800.CrossRefPubMed
8.
go back to reference Haddow LJ, Dave B, Mindel A, McPhie KA, Chung C, Marks C, Dwyer DE. Increase in rates of herpes simplex virus type 1 as a cause of anogenital herpes in western Sydney, Australia, between 1979 and 2003. Sex Transm Infect. 2006;82(3):255–9.CrossRefPubMedPubMedCentral Haddow LJ, Dave B, Mindel A, McPhie KA, Chung C, Marks C, Dwyer DE. Increase in rates of herpes simplex virus type 1 as a cause of anogenital herpes in western Sydney, Australia, between 1979 and 2003. Sex Transm Infect. 2006;82(3):255–9.CrossRefPubMedPubMedCentral
9.
go back to reference Kortekangas-Savolainen O, Vuorinen T. Trends in herpes simplex virus type 1 and 2 infections among patients diagnosed with genital herpes in a Finnish sexually transmitted disease clinic, 1994–2002. Sex Transm Infect. 2007;34(1):37–40.CrossRef Kortekangas-Savolainen O, Vuorinen T. Trends in herpes simplex virus type 1 and 2 infections among patients diagnosed with genital herpes in a Finnish sexually transmitted disease clinic, 1994–2002. Sex Transm Infect. 2007;34(1):37–40.CrossRef
10.
go back to reference Samra Z, Scherf E, Dan M. Herpes simplex virus type 1 is the prevailing cause of genital herpes in the Tel Aviv area, Israel. Sex Transm Infect. 2003;30(10):794–6.CrossRef Samra Z, Scherf E, Dan M. Herpes simplex virus type 1 is the prevailing cause of genital herpes in the Tel Aviv area, Israel. Sex Transm Infect. 2003;30(10):794–6.CrossRef
11.
go back to reference Nieuwenhuis RF, van Doornum GJ, Mulder PG, Neumann HA, van der Meijden WI. Importance of herpes simplex virus type-1 (HSV-1) in primary genital herpes. Acta Derm Venereol. 2006;86(2):129–34.PubMed Nieuwenhuis RF, van Doornum GJ, Mulder PG, Neumann HA, van der Meijden WI. Importance of herpes simplex virus type-1 (HSV-1) in primary genital herpes. Acta Derm Venereol. 2006;86(2):129–34.PubMed
12.
go back to reference Bernstein DI, Bellamy AR, Hook 3rd EW, Levin MJ, Wald A, Ewell MG, Wolff PA, Deal CD, Heineman TC, Dubin G, et al. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis. 2013;56(3):344–51.CrossRefPubMed Bernstein DI, Bellamy AR, Hook 3rd EW, Levin MJ, Wald A, Ewell MG, Wolff PA, Deal CD, Heineman TC, Dubin G, et al. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis. 2013;56(3):344–51.CrossRefPubMed
13.
go back to reference Reeves WC, Corey L, Adams HG, Vontver LA, Holmes KK. Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response. N Engl J Med. 1981;305(6):315–9.CrossRefPubMed Reeves WC, Corey L, Adams HG, Vontver LA, Holmes KK. Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response. N Engl J Med. 1981;305(6):315–9.CrossRefPubMed
14.
go back to reference Vyse AJ, Gay NJ, Slomka MJ, Gopal R, Gibbs T, Morgan-Capner P, Brown DW. The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect. 2000;76(3):183–7.CrossRefPubMedPubMedCentral Vyse AJ, Gay NJ, Slomka MJ, Gopal R, Gibbs T, Morgan-Capner P, Brown DW. The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect. 2000;76(3):183–7.CrossRefPubMedPubMedCentral
15.
go back to reference Bradley H, Markowitz LE, Gibson T, McQuillan GM. Seroprevalence of Herpes Simplex Virus Types 1 and 2--United States, 1999–2010. J Infect Dis. 2014;209(3):325-33. Bradley H, Markowitz LE, Gibson T, McQuillan GM. Seroprevalence of Herpes Simplex Virus Types 1 and 2--United States, 1999–2010. J Infect Dis. 2014;209(3):325-33.
16.
go back to reference De Melker HE, Conyn-van Spaendonck MA. Immunosurveillance and the evaluation of national immunization programmes: a population-based approach. Epidemiol Infect. 1998;121(3):637–43.CrossRefPubMedPubMedCentral De Melker HE, Conyn-van Spaendonck MA. Immunosurveillance and the evaluation of national immunization programmes: a population-based approach. Epidemiol Infect. 1998;121(3):637–43.CrossRefPubMedPubMedCentral
17.
go back to reference van der Klis FR, Mollema L, Berbers GA, de Melker HE, Coutinho RA. Second national serum bank for population-based seroprevalence studies in the Netherlands. Neth J Med. 2009;67(7):301–8.PubMed van der Klis FR, Mollema L, Berbers GA, de Melker HE, Coutinho RA. Second national serum bank for population-based seroprevalence studies in the Netherlands. Neth J Med. 2009;67(7):301–8.PubMed
18.
go back to reference Focus Diagnostics. HerpeSelect® 1 ELISA IgG. Cypress: Focus Diagnostics; 2011. Focus Diagnostics. HerpeSelect® 1 ELISA IgG. Cypress: Focus Diagnostics; 2011.
19.
go back to reference Focus Diagnostics. HerpeSelect® 2 ELISA IgG. Cypress: Focus Diagnostics; 2011. Focus Diagnostics. HerpeSelect® 2 ELISA IgG. Cypress: Focus Diagnostics; 2011.
20.
go back to reference Pebody RG, Andrews N, Brown D, Gopal R, De Melker H, Francois G, Gatcheva N, Hellenbrand W, Jokinen S, Klavs I, et al. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect. 2004;80(3):185–91.CrossRefPubMedPubMedCentral Pebody RG, Andrews N, Brown D, Gopal R, De Melker H, Francois G, Gatcheva N, Hellenbrand W, Jokinen S, Klavs I, et al. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect. 2004;80(3):185–91.CrossRefPubMedPubMedCentral
21.
go back to reference Rust K. Variance estimation for complex estimators in sample surveys. J Off Stat. 1985;1(4):381–97. Rust K. Variance estimation for complex estimators in sample surveys. J Off Stat. 1985;1(4):381–97.
22.
go back to reference Zhang J, Yu KF. What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690–1.CrossRefPubMed Zhang J, Yu KF. What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690–1.CrossRefPubMed
23.
24.
go back to reference Kramer MA, Uitenbroek DG, Ujcic-Voortman JK, Pfrommer C, Spaargaren J, Coutinho RA, Dukers-Muijrers NH. Ethnic differences in HSV1 and HSV2 seroprevalence in Amsterdam, the Netherlands. Euro Surveill. 2008;13:24. Kramer MA, Uitenbroek DG, Ujcic-Voortman JK, Pfrommer C, Spaargaren J, Coutinho RA, Dukers-Muijrers NH. Ethnic differences in HSV1 and HSV2 seroprevalence in Amsterdam, the Netherlands. Euro Surveill. 2008;13:24.
25.
go back to reference Cherpes TL, Meyn LA, Hillier SL. Cunnilingus and vaginal intercourse are risk factors for herpes simplex virus type 1 acquisition in women. Sex Transm Dis. 2005;32(2):84–9.CrossRefPubMed Cherpes TL, Meyn LA, Hillier SL. Cunnilingus and vaginal intercourse are risk factors for herpes simplex virus type 1 acquisition in women. Sex Transm Dis. 2005;32(2):84–9.CrossRefPubMed
26.
go back to reference De Melker HE, Nagelkerde NJ, Conyn-van Spaendonck MA. Non-participation in a population-based seroprevalence study of vaccine-preventable diseases. Epidemiol Infect. 2000;124(2):255–62.CrossRefPubMedPubMedCentral De Melker HE, Nagelkerde NJ, Conyn-van Spaendonck MA. Non-participation in a population-based seroprevalence study of vaccine-preventable diseases. Epidemiol Infect. 2000;124(2):255–62.CrossRefPubMedPubMedCentral
27.
go back to reference Looker KJ, Magaret AS, Turner KM, Vickerman P, Gottlieb SL, Newman LM. Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PLoS One. 2015;10(1):e114989.CrossRefPubMedPubMedCentral Looker KJ, Magaret AS, Turner KM, Vickerman P, Gottlieb SL, Newman LM. Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PLoS One. 2015;10(1):e114989.CrossRefPubMedPubMedCentral
28.
go back to reference Puhakka L, Sarvikivi E, Lappalainen M, Surcel HM, Saxen H. Decrease in seroprevalence for herpesviruses among pregnant women in Finland: cross-sectional study of three time points 1992, 2002 and 2012. Infect Dis (Lond). 2016;48(5):406-10. Puhakka L, Sarvikivi E, Lappalainen M, Surcel HM, Saxen H. Decrease in seroprevalence for herpesviruses among pregnant women in Finland: cross-sectional study of three time points 1992, 2002 and 2012. Infect Dis (Lond). 2016;48(5):406-10.
29.
go back to reference Wald A, Langenberg AG, Krantz E, Douglas Jr JM, Handsfield HH, DiCarlo RP, Adimora AA, Izu AE, Morrow RA, Corey L. The relationship between condom use and herpes simplex virus acquisition. Ann Intern Med. 2005;143(10):707–13.CrossRefPubMed Wald A, Langenberg AG, Krantz E, Douglas Jr JM, Handsfield HH, DiCarlo RP, Adimora AA, Izu AE, Morrow RA, Corey L. The relationship between condom use and herpes simplex virus acquisition. Ann Intern Med. 2005;143(10):707–13.CrossRefPubMed
30.
go back to reference Cowan FM, Copas A, Johnson AM, Ashley R, Corey L, Mindel A. Herpes simplex virus type 1 infection: a sexually transmitted infection of adolescence? Sexually transmitted infections. 2002;78(5):346–8.CrossRefPubMedPubMedCentral Cowan FM, Copas A, Johnson AM, Ashley R, Corey L, Mindel A. Herpes simplex virus type 1 infection: a sexually transmitted infection of adolescence? Sexually transmitted infections. 2002;78(5):346–8.CrossRefPubMedPubMedCentral
31.
go back to reference Schillinger JA, Xu F, Sternberg MR, Armstrong GL, Lee FK, Nahmias AJ, McQuillan GM, Louis ME, Markowitz LE. National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976–1994. Sex Transm Dis. 2004;31(12):753–60.CrossRefPubMed Schillinger JA, Xu F, Sternberg MR, Armstrong GL, Lee FK, Nahmias AJ, McQuillan GM, Louis ME, Markowitz LE. National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976–1994. Sex Transm Dis. 2004;31(12):753–60.CrossRefPubMed
32.
go back to reference Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, Berman SM, Markowitz LE. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. 2006;296(8):964–73.CrossRefPubMed Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, Berman SM, Markowitz LE. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. 2006;296(8):964–73.CrossRefPubMed
33.
go back to reference Rotermann M, Langlois KA, Severini A, Totten S. Prevalence of chlamydia trachomatis and herpes simplex virus type 2: Results from the 2009 to 2011 Canadian Health Measures Survey. Health reports / Statistics Canada, Canadian Centre for Health Information = Rapports sur la sante / Statistique Canada, Centre canadien d’information sur la sante. 2013;24(4):10–5. Rotermann M, Langlois KA, Severini A, Totten S. Prevalence of chlamydia trachomatis and herpes simplex virus type 2: Results from the 2009 to 2011 Canadian Health Measures Survey. Health reports / Statistics Canada, Canadian Centre for Health Information = Rapports sur la sante / Statistique Canada, Centre canadien d’information sur la sante. 2013;24(4):10–5.
34.
go back to reference Bunzli D, Wietlisbach V, Barazzoni F, Sahli R, Meylan PR. Seroepidemiology of herpes simplex virus type 1 and 2 in Western and Southern Switzerland in adults aged 25–74 in 1992–93: a population-based study. BMC Infect Dis. 2004;4:10.CrossRefPubMedPubMedCentral Bunzli D, Wietlisbach V, Barazzoni F, Sahli R, Meylan PR. Seroepidemiology of herpes simplex virus type 1 and 2 in Western and Southern Switzerland in adults aged 25–74 in 1992–93: a population-based study. BMC Infect Dis. 2004;4:10.CrossRefPubMedPubMedCentral
35.
go back to reference Page A, Taylor R, Richters J, Shaw J, Taylor J, Cunningham A, Mindel A. Upstairs and downstairs: socio-economic and gender interactions in herpes simplex virus type 2 seroprevalence in australia. Sex Transm Dis. 2009;36(6):344–9.CrossRefPubMed Page A, Taylor R, Richters J, Shaw J, Taylor J, Cunningham A, Mindel A. Upstairs and downstairs: socio-economic and gender interactions in herpes simplex virus type 2 seroprevalence in australia. Sex Transm Dis. 2009;36(6):344–9.CrossRefPubMed
36.
go back to reference Looker KJ, Garnett GP. A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2. Sex Transm Dis. 2005;81(2):103–7.CrossRef Looker KJ, Garnett GP. A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2. Sex Transm Dis. 2005;81(2):103–7.CrossRef
37.
go back to reference Johnston C, Koelle DM, Wald A. Current status and prospects for development of an HSV vaccine. Vaccine. 2014;32(14):1553–60.CrossRefPubMed Johnston C, Koelle DM, Wald A. Current status and prospects for development of an HSV vaccine. Vaccine. 2014;32(14):1553–60.CrossRefPubMed
Metadata
Title
Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period
Authors
Petra J. Woestenberg
Jeroen H. T. Tjhie
Hester E. de Melker
Fiona R. M. van der Klis
Jan E. A. M van Bergen
Marianne A. B. van der Sande
Birgit H. B. van Benthem
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2016
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-1707-8

Other articles of this Issue 1/2016

BMC Infectious Diseases 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.